HomeCompareORINF vs YUM

ORINF vs YUM: Dividend Comparison 2026

ORINF yields 2.71% · YUM yields 1.86%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 YUM wins by $81.3K in total portfolio value· pulled ahead in Year 2
10 years
ORINF
ORINF
● Live price
2.71%
Share price
$78.95
Annual div
$2.14
5Y div CAGR
9.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.6K
Annual income
$871.03
Full ORINF calculator →
YUM
YUM
● Live price
1.86%
Share price
$154.59
Annual div
$2.88
5Y div CAGR
51.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$107.9K
Annual income
$40,443.52
Full YUM calculator →

Portfolio growth — ORINF vs YUM

📍 YUM pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodORINFYUM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ORINF + YUM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ORINF pays
YUM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ORINF
Annual income on $10K today (after 15% tax)
$230.40/yr
After 10yr DRIP, annual income (after tax)
$740.38/yr
YUM
Annual income on $10K today (after 15% tax)
$158.35/yr
After 10yr DRIP, annual income (after tax)
$34,376.99/yr
At 15% tax rate, YUM beats the other by $33,636.62/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ORINF + YUM for your $10,000?

ORINF: 50%YUM: 50%
100% YUM50/50100% ORINF
Portfolio after 10yr
$67.3K
Annual income
$20,657.28/yr
Blended yield
30.71%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on YUM right now

ORINF
No analyst data
Altman Z
11.2
Piotroski
7/9
YUM
Analyst Ratings
18
Buy
30
Hold
3
Sell
Consensus: Hold
Price Target
$173.15
+12.0% upside vs current
Range: $158.00 — $190.00
Altman Z
2.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ORINF buys
0
YUM buys
0
No recent congressional trades found for ORINF or YUM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricORINFYUM
Forward yield2.71%1.86%
Annual dividend / share$2.14$2.88
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR9.4%51.4%
Portfolio after 10y$26.6K$107.9K
Annual income after 10y$871.03$40,443.52
Total dividends collected$5.4K$81.2K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: ORINF vs YUM ($10,000, DRIP)

YearORINF PortfolioORINF Income/yrYUM PortfolioYUM Income/yrGap
1$10,997$296.54$10,982$282.06+$15.00ORINF
2← crossover$12,100$333.40$12,189$438.29$89.00YUM
3$13,322$375.08$13,731$688.32$409.00YUM
4$14,676$422.22$15,789$1,097.12$1.1KYUM
5$16,179$475.59$18,679$1,785.08$2.5KYUM
6$17,848$536.06$22,975$2,988.18$5.1KYUM
7$19,702$604.60$29,784$5,200.49$10.1KYUM
8$21,764$682.38$41,408$9,539.16$19.6KYUM
9$24,058$770.69$63,071$18,765.27$39.0KYUM
10$26,613$871.03$107,930$40,443.52$81.3KYUM

ORINF vs YUM: Complete Analysis 2026

ORINFStock

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, other European countries, North America, and internationally. It provides prescription drugs and self-care products, including Nubeqa for the treatment of prostate cancer; dexdor and Precedex for intensive care sedative; Stalevo and Comtess/Comtan for Parkinson's disease; Simdax for acute decompensated heart failure; and Fareston for breast cancer, as well as Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. The company also offers veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; and APIs for generic and proprietary drugs, as well as provides contract manufacturing services. In addition, it markets and sells veterinary drugs manufactured by other international companies. The company serves various healthcare service providers and professionals, such as specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories, as well as consumers with pets. Orion Oyj has partnership with Propeller Health to connect the Easyhaler(R) product portfolio for the treatment of asthma and COPD; and a research collaboration and license agreement with Alligator Bioscience AB (publ) to discover and develop new bispecific antibody cancer therapeutics. Orion Oyj was founded in 1917 and is headquartered in Espoo, Finland.

Full ORINF Calculator →

YUMConsumer Discretionary

YUM! Brands, Inc., together with its subsidiaries, develops, operates, and franchises quick service restaurants worldwide. It operates through four segments: the KFC Division, the Taco Bell Division, the Pizza Hut Division, and the Habit Burger Grill Division. The company operates restaurants under the KFC, Pizza Hut, Taco Bell, and The Habit Burger Grill brands, which specialize in chicken, pizza, made-to-order chargrilled burgers, sandwiches, Mexican-style food categories, and other food products. As of December 31, 2021, it had 26,934 KFC units; 18,381 Pizza Hut units; 7,791 Taco Bell units; and 318 The Habit Burger Grill units in approximately 157 countries and territories. The company was formerly known as TRICON Global Restaurants, Inc. and changed its name to YUM! Brands, Inc. in May 2002. YUM! Brands, Inc. was incorporated in 1997 and is headquartered in Louisville, Kentucky.

Full YUM Calculator →
📬

Get this ORINF vs YUM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ORINF vs SCHDORINF vs JEPIORINF vs OORINF vs KOORINF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.